Bayer is a globalized innovation company with core competencies in the fields of health care and agriculture. Bayer develops new molecules for use in innovative products and solutions to improve the health of humans, animals and plants. Its research and development activities are based on a profound understanding of the biochemical processes in living organisms. Through its products, Bayer is contributing to finding solutions to some of the major challenges of our time. The growing and increasingly aging world population requires improved medical care and an adequate supply of food. Bayer is improving people’s quality of life by preventing, alleviating and curing diseases and the company is helping provide a reliable supply of high-quality food, feed and plant-based raw materials.

Due to the increased scrutiny of regulatory authorities on the quality of clinical trial data, and increased business demands to conduct clinical trials in an efficient manner, the focus of the CRA II
position is strengthened to reflect greater focus on quality and oversight and achieving commitments.